Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-059558
Filing Date
2025-04-29
Accepted
2025-04-29 07:10:41
Documents
20
Period of Report
2025-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A qttb-20250429.htm   iXBRL DEF 14A 1353577
2 GRAPHIC img227821128_0.jpg GRAPHIC 32642
3 GRAPHIC img227821128_1.jpg GRAPHIC 32642
4 GRAPHIC img227821128_2.jpg GRAPHIC 1092376
5 GRAPHIC img227821128_3.jpg GRAPHIC 1259384
6 GRAPHIC img227821128_4.jpg GRAPHIC 510847
7 GRAPHIC img227821128_5.jpg GRAPHIC 329437
  Complete submission text file 0000950170-25-059558.txt   10531361

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT qttb-20250429.xsd EX-101.SCH 15224
23 EXTRACTED XBRL INSTANCE DOCUMENT qttb-20250429_htm.xml XML 732040
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Filer) CIK: 0001661998 (see all company filings)

EIN.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38433 | Film No.: 25882632
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)